These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34857854)

  • 1. Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2.
    Shimizu K; Iyoda T; Sanpei A; Nakazato H; Okada M; Ueda S; Kato-Murayama M; Murayama K; Shirouzu M; Harada N; Hidaka M; Fujii SI
    Commun Biol; 2021 Dec; 4(1):1365. PubMed ID: 34857854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
    Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of highly cytotoxic CD8
    Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
    Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Lineburg KE; Grant EJ; Swaminathan S; Chatzileontiadou DSM; Szeto C; Sloane H; Panikkar A; Raju J; Crooks P; Rehan S; Nguyen AT; Lekieffre L; Neller MA; Tong ZWM; Jayasinghe D; Chew KY; Lobos CA; Halim H; Burrows JM; Riboldi-Tunnicliffe A; Chen W; D'Orsogna L; Khanna R; Short KR; Smith C; Gras S
    Immunity; 2021 May; 54(5):1055-1065.e5. PubMed ID: 33945786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A
    Nesterenko PA; McLaughlin J; Tsai BL; Burton Sojo G; Cheng D; Zhao D; Mao Z; Bangayan NJ; Obusan MB; Su Y; Ng RH; Chour W; Xie J; Li YR; Lee D; Noguchi M; Carmona C; Phillips JW; Kim JT; Yang L; Heath JR; Boutros PC; Witte ON
    Cell Rep; 2021 Dec; 37(13):110167. PubMed ID: 34919800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
    Mahajan S; Kode V; Bhojak K; Karunakaran C; Lee K; Manoharan M; Ramesh A; Hv S; Srivastava A; Sathian R; Khan T; Kumar P; Gupta R; Chakraborty P; Chaudhuri A
    Sci Rep; 2021 Jun; 11(1):13164. PubMed ID: 34162945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
    Schmidt KG; Nganou-Makamdop K; Tenbusch M; El Kenz B; Maier C; Lapuente D; Überla K; Spriewald B; Bergmann S; Harrer EG; Harrer T
    Front Immunol; 2021; 12():627568. PubMed ID: 33995351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
    Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
    Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Candidate CD8
    Pushpakumara PD; Madhusanka D; Dhanasekara S; Jeewandara C; Ogg GS; Malavige GN
    Viruses; 2021 May; 13(6):. PubMed ID: 34073934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents.
    Wang X; Zhang J; Liu M; Guo Y; Guo P; Yang X; Shang B; Li M; Tian J; Zhang T; Wang X; Jin R; Zhou J; Gao GF; Liu J
    Signal Transduct Target Ther; 2024 Jun; 9(1):160. PubMed ID: 38866784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants.
    Deng S; Xu Z; Wang M; Hu J; Liu Z; Zhu F; Zheng P; Kombe Kombe AJ; Zhang H; Wu S; Jin T
    J Biol Chem; 2024 Aug; 300(8):107563. PubMed ID: 39002680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.
    Grifoni A; Sidney J; Vita R; Peters B; Crotty S; Weiskopf D; Sette A
    Cell Host Microbe; 2021 Jul; 29(7):1076-1092. PubMed ID: 34237248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-Cell Receptors Cross-Reactive to Coronaviral Epitopes Homologous to the SPR Peptide.
    Serdyuk YV; Zornikova KV; Dianov DV; Ivanova NO; Davydova VD; Fefelova EI; Nenasheva TA; Sheetikov SA; Bogolyubova AV
    Biochemistry (Mosc); 2024 Sep; 89(9):1631-1642. PubMed ID: 39418521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a SARS-CoV-2 specific CD8
    Gangaev A; Ketelaars SLC; Isaeva OI; Patiwael S; Dopler A; Hoefakker K; De Biasi S; Gibellini L; Mussini C; Guaraldi G; Girardis M; Ormeno CMPT; Hekking PJM; Lardy NM; Toebes M; Balderas R; Schumacher TN; Ovaa H; Cossarizza A; Kvistborg P
    Nat Commun; 2021 May; 12(1):2593. PubMed ID: 33972535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR.
    Szeto C; Nguyen AT; Lobos CA; Chatzileontiadou DSM; Jayasinghe D; Grant EJ; Riboldi-Tunnicliffe A; Smith C; Gras S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Avidity CD4
    Bacher P; Rosati E; Esser D; Martini GR; Saggau C; Schiminsky E; Dargvainiene J; Schröder I; Wieters I; Khodamoradi Y; Eberhardt F; Vehreschild MJGT; Neb H; Sonntagbauer M; Conrad C; Tran F; Rosenstiel P; Markewitz R; Wandinger KP; Augustin M; Rybniker J; Kochanek M; Leypoldt F; Cornely OA; Koehler P; Franke A; Scheffold A
    Immunity; 2020 Dec; 53(6):1258-1271.e5. PubMed ID: 33296686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-dependent variation in SARS-CoV-2 CD8 
    Buckley PR; Lee CH; Pereira Pinho M; Ottakandathil Babu R; Woo J; Antanaviciute A; Simmons A; Ogg G; Koohy H
    Immunology; 2022 May; 166(1):78-103. PubMed ID: 35143694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.